|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Net sales | |||||
| Products | |||||
| Services | |||||
| Total net sales | |||||
| Cost of sales | |||||
| Products | |||||
| Services | |||||
| Total cost of sales | |||||
| Gross profit | |||||
| Operating expenses | |||||
| Research and development, net | |||||
| Selling, general and administrative | |||||
| Total operating expenses | |||||
| Operating loss | |||||
| Gain from deconsolidation of subsidiary | |||||
| Gain from step acquisition | |||||
| Financial income (expenses), net | |||||
| Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest, Total | |||||
| Income tax benefit (expenses) | |||||
| Share in net profits (losses) of associated companies | |||||
| Net loss | |||||
| Other comprehensive income (loss), net of tax: | |||||
| Foreign currency translation adjustments | |||||
| Unrealized gains (losses) on derivatives designated as cash flow hedge | |||||
| Other comprehensive income (loss) | |||||
| Comprehensive loss | |||||
| Earnings Per Share, Basic | |||||
| Weighted average shares outstanding - basic and diluted (in Shares) | |||||
Loading...